Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, has appointed Juan Carlos Jaramillo, MD as chief medical officer and member of the Management Board starting October 1, 2020. Jaramillo will succeed Wolfgang Bender, MD, PhD who will retire after a hand-over period, at the end of October 2020.   Jaramillo has broad international experience and strong expertise in medical affairs and clinical development, including vaccines. Due to his diverse pharma...